PL3621614T3
Lotion comprising tazarotene for topical use in the treatment of acne
Abstract
This record has no abstract on file.
Term
11.6 yearsto projected expiry
Projected expiry 11 May 2038, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
57 members in 20 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201762505421 | United States of America | P | |
| 2018032359 | United States of America | W |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| CA2988577A1 | Canada | A1 | |
| US2016367570A1 | United States of America | A1 | |
| WO2016205001A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2016279801A1 | Australia | A1 | |
| EP3310389A1 | European Patent Office (EPO) | A1 | |
| KR20180053292A | Republic of Korea | A | |
| US2018177803A1 | United States of America | A1 | |
| CN108282998A | China | A | |
| BR112017027332A2 | Brazil | A2 | |
| JP2018526325A | Japan | A | |
| MX2017015990A | Mexico | A | |
| CA3063371A1 | Canada | A1 | |
| WO2018209262A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2018360752A1 | United States of America | A1 | |
| US10251895B2 | United States of America | B2 | |
| US2019133942A1 | United States of America | A1 | |
| US2019133943A1 | United States of America | A1 | |
| US2019231797A1 | United States of America | A1 | |
| US10426787B2 | United States of America | B2 | |
| EP3621614A1 | European Patent Office (EPO) | A1 | |
| BR112019023817A2 | Brazil | A2 | |
| EP3310389B1 | European Patent Office (EPO) | B1 | |
| JP2020519656A | Japan | A | |
| DK3310389T3 | Denmark | T3 | |
| RS60672B1 | Serbia | B1 | |
| LT3310389T | Lithuania | T | |
| PT3310389T | Portugal | T | |
| HRP20201250T1 | Croatia | T1 | |
| PL3310389T3 | Poland | T3 | |
| SI3310389T1 | Slovenia | T1 | |
| HUE050603T2 | Hungary | T2 | |
| ES2812451T3 | Spain | T3 | |
| US2021145847A1 | United States of America | A1 | |
| CN108282998B | China | B | |
| AU2016279801B2 | Australia | B2 | |
| US2021330681A1 | United States of America | A1 | |
| CY1123354T1 | Cyprus | T1 | |
| JP6997624B2 | Japan | B2 | |
| US11311482B2 | United States of America | B2 | |
| US2022233439A1 | United States of America | A1 | |
| BR112019023817A8 | Brazil | A8 | |
| US2023086282A1 | United States of America | A1 | |
| US11648256B2 | United States of America | B2 | |
| US11679115B2 | United States of America | B2 | |
| US11679116B2 | United States of America | B2 | |
| BR112017027332B1 | Brazil | B1 | |
| US2023355640A1 | United States of America | A1 | |
| JP7410720B2 | Japan | B2 | |
| KR102643849B1 | Republic of Korea | B1 | |
| KR20240035898A | Republic of Korea | A | |
| US12128137B2 | United States of America | B2 | |
| US2025017854A1 | United States of America | A1 | |
| KR102779108B1 | Republic of Korea | B1 | |
| MX377544B | Mexico | B | |
| EP3621614B1 | European Patent Office (EPO) | B1 | |
| PL3621614T3This record | Poland | T3 | |
| RS67211B1 | Serbia | B1 |
Numbers
- Publication
- 3621614
- Application
- 18727965
Titles2
- English
- LOTION COMPRISING TAZAROTENE FOR TOPICAL USE IN THE TREATMENT OF ACNE
- Polish
- Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku
Classification
- CPC, 9
- A61K9/107
- A61K9/0014
- A61K47/14
- A61K9/06
- A61K47/32
- A61K47/44
- A61K31/4436
- A61P17/10
- A61K47/34
- IPC, 8
- A61K31 4436
- A61K9 00
- A61K9 06
- A61K9 107
- A61K47 14
- A61K47 32
- A61K47 44
- A61P17 10